WO2024213932 - DRIVING AXON REGENERATION BY NOVEL ENPP1 INHIBITORS
National phase entry is expected:
Publication Number
WO/2024/213932
Publication Date
17.10.2024
International Application No.
PCT/IB2024/000162
International Filing Date
09.04.2024
Title **
[English]
DRIVING AXON REGENERATION BY NOVEL ENPP1 INHIBITORS
[French]
COMMANDE DE RÉGÉNÉRATION D'AXONES PAR DE NOUVEAUX INHIBITEURS D'ENPP1
Applicants **
THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY
Inventors
LIU, Kai
HUANG, Yong
CHAN, Leung, Ting
YANG, Chao
Priority Data
63/495,541
11.04.2023
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CNIPA
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1605 | |
| EPO | Filing, Examination, Granting | 11576 | |
| Japan | Filing, Examination, Granting | 2031 | |
| South Korea | Filing, Examination, Granting | 1871 | |
| USA | Filing, Examination, Granting | 5340 |

Total:
22,423
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
A neurite growth stimulator is a small molecule ENPP1 inhibitor. The small molecule ENPP1 inhibitor allows treatment of a central nervous system (CNS) injury with promotion of axon regeneration. The ENPP1 inhibitor in a vehicle can be administered to a neurological injury to promote the regeneration of axons.[French]
Un stimulateur de croissance de neurites est un inhibiteur d'ENPP1 à petites molécules. L'inhibiteur d'ENPP1 à petites molécules permet le traitement d'une lésion du système nerveux central (SNC) avec la promotion de la régénération d'axones. L'inhibiteur d'ENPP1 dans un véhicule peut être administré à une lésion neurologique pour favoriser la régénération d'axones.